MANKIND.NS · Mankind Pharma Limited
India · RS rating 65 · As of 2026-10-14
| Price | 2,335.00 INR |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 77 / 44 / 60 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 39 / 51 / 42 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +2.5% |
| Sales growth Q/Q | +17.1% |
| Distance from 52-week high | +10.8% |
| Market cap (USD) | $10.3B |